SPI Pharma is a leader in technologies focused to pediatric or patient-friendly dose forms. ACTILLETS? and TAP? pellet technology offer a promising solution for the development of oral drug formulations that require precise control over drug release and dosing. Our MCC and tartaric acid spheres production benefits from the requirements of manufacturing GMP Excipients. For more information and to request samples, click the link: https://lnkd.in/eU-qPif
??????????????? ??????-?????? – ?? ???????? ???? ?? ???????????? In the realm of pharmaceutical formulations, the quest for efficient and reliable drug delivery systems has led to significant advancements. Among these,?CELLETS?—highly spherical microcrystalline cellulose (MCC) pellets—have emerged as a pivotal component in developing multiparticulate dosage forms for oral applications. These neutral starter cores offer a versatile platform for active pharmaceutical ingredient (API) layering and?coating, enabling controlled and sustained release profiles. Read more in the article. #Cellets #MCC #pellets